CA Stock MarketDetailed Quotes

ENBI Entheon Biomedical Corp

Watchlist
  • 0.100
  • 0.0000.00%
15min DelayMarket Closed Apr 29 15:06 ET
1.39MMarket Cap-2.50P/E (TTM)

Entheon Biomedical Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 28, 2025
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
49.95%-94.71K
75.45%-359.93K
27.01%-46.57K
-143.90%-147.78K
103.19%23.68K
Net income from continuing operations
-94.51%-145.61K
-5.97%-317.92K
-12.39%-83.8K
50.17%-64.7K
---94.56K
21.69%-74.86K
85.45%-300K
69.43%-74.56K
-119.23%-129.85K
--0
Operating gains losses
----
----
----
----
----
----
-100.83%-4.4K
----
----
----
Unrealized gains and losses of investment securities
----
----
----
----
----
----
----
----
----
101.42%5.45K
Remuneration paid in stock
----
--0
--0
--0
----
----
-98.62%1.18K
100.01%21
30.77%-1.18K
-99.05%840
Change In working capital
272.64%34.28K
33.50%-37.72K
-125.66%-8.31K
76.77%-5.84K
-121.40%-3.72K
75.59%-19.85K
-112.98%-56.71K
-91.23%32.37K
93.24%-25.12K
-79.09%17.4K
-Change in receivables
-770.05%-1.89K
-94.45%1.99K
-103.90%-178
99.00%-38
-96.80%2.43K
99.47%-217
596.75%35.89K
-61.51%4.56K
75.49%-3.79K
1,198.87%75.92K
-Change in prepaid assets
-14.70%12.52K
124.95%5.81K
-63.71%-27.75K
-42.65%15.56K
4.45%3.31K
140.07%14.68K
-102.16%-23.27K
-106.62%-16.95K
-91.41%27.14K
-98.79%3.17K
-Change in payables and accrued expense
168.90%23.64K
34.34%-45.52K
-56.16%19.62K
55.93%-21.36K
84.67%-9.46K
-776.08%-34.32K
89.06%-69.32K
-55.84%44.76K
92.79%-48.47K
64.24%-61.7K
Cash from discontinued investing activities
Operating cash flow
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
49.95%-94.71K
81.59%-359.93K
52.82%-46.57K
-184.06%-147.78K
102.85%23.68K
Investing cash flow
Cash flow from continuing investing activities
0
0
-95.99%24.4K
-98.21%9.4K
Net investment purchase and sale
----
--0
----
----
----
----
-99.31%4.4K
----
----
----
Net other investing changes
----
----
----
----
----
----
180.00%20K
--5K
----
----
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
----
----
----
-95.83%24.4K
-98.23%9.4K
----
----
Financing cash flow
Cash flow from continuing financing activities
500K
147.5K
0
0
147.5K
0
0
0
0
Net common stock issuance
--500K
----
----
--0
--147.5K
--0
----
----
--0
----
Net other financing activities
----
--147.5K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--500K
--147.5K
--0
--0
--147.5K
--0
--0
--0
--0
----
Net cash flow
Beginning cash position
-60.39%136.49K
-49.33%344.63K
-40.13%228.6K
-39.07%299.14K
-49.09%249.92K
-49.33%344.63K
-66.81%680.17K
53.72%381.81K
4.99%490.91K
-40.23%490.91K
Current changes in cash
510.37%388.67K
37.97%-208.14K
-147.75%-92.11K
35.35%-70.54K
--49.22K
49.95%-94.71K
75.49%-335.53K
-108.61%-37.18K
50.23%-109.1K
--0
End cash Position
110.13%525.16K
-60.39%136.49K
-60.39%136.49K
-40.13%228.6K
-39.07%299.14K
-49.09%249.92K
-49.33%344.63K
-49.33%344.63K
53.72%381.81K
4.99%490.91K
Free cash from
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
49.95%-94.71K
81.59%-359.93K
52.82%-46.57K
-184.06%-147.78K
102.85%23.68K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Feb 28, 2025(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K49.95%-94.71K75.45%-359.93K27.01%-46.57K-143.90%-147.78K103.19%23.68K
Net income from continuing operations -94.51%-145.61K-5.97%-317.92K-12.39%-83.8K50.17%-64.7K---94.56K21.69%-74.86K85.45%-300K69.43%-74.56K-119.23%-129.85K--0
Operating gains losses -------------------------100.83%-4.4K------------
Unrealized gains and losses of investment securities ------------------------------------101.42%5.45K
Remuneration paid in stock ------0--0--0---------98.62%1.18K100.01%2130.77%-1.18K-99.05%840
Change In working capital 272.64%34.28K33.50%-37.72K-125.66%-8.31K76.77%-5.84K-121.40%-3.72K75.59%-19.85K-112.98%-56.71K-91.23%32.37K93.24%-25.12K-79.09%17.4K
-Change in receivables -770.05%-1.89K-94.45%1.99K-103.90%-17899.00%-38-96.80%2.43K99.47%-217596.75%35.89K-61.51%4.56K75.49%-3.79K1,198.87%75.92K
-Change in prepaid assets -14.70%12.52K124.95%5.81K-63.71%-27.75K-42.65%15.56K4.45%3.31K140.07%14.68K-102.16%-23.27K-106.62%-16.95K-91.41%27.14K-98.79%3.17K
-Change in payables and accrued expense 168.90%23.64K34.34%-45.52K-56.16%19.62K55.93%-21.36K84.67%-9.46K-776.08%-34.32K89.06%-69.32K-55.84%44.76K92.79%-48.47K64.24%-61.7K
Cash from discontinued investing activities
Operating cash flow -17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K49.95%-94.71K81.59%-359.93K52.82%-46.57K-184.06%-147.78K102.85%23.68K
Investing cash flow
Cash flow from continuing investing activities 00-95.99%24.4K-98.21%9.4K
Net investment purchase and sale ------0-----------------99.31%4.4K------------
Net other investing changes ------------------------180.00%20K--5K--------
Cash from discontinued investing activities
Investing cash flow ------0--0-------------95.83%24.4K-98.23%9.4K--------
Financing cash flow
Cash flow from continuing financing activities 500K147.5K00147.5K0000
Net common stock issuance --500K----------0--147.5K--0----------0----
Net other financing activities ------147.5K--------------------------------
Cash from discontinued financing activities
Financing cash flow --500K--147.5K--0--0--147.5K--0--0--0--0----
Net cash flow
Beginning cash position -60.39%136.49K-49.33%344.63K-40.13%228.6K-39.07%299.14K-49.09%249.92K-49.33%344.63K-66.81%680.17K53.72%381.81K4.99%490.91K-40.23%490.91K
Current changes in cash 510.37%388.67K37.97%-208.14K-147.75%-92.11K35.35%-70.54K--49.22K49.95%-94.71K75.49%-335.53K-108.61%-37.18K50.23%-109.1K--0
End cash Position 110.13%525.16K-60.39%136.49K-60.39%136.49K-40.13%228.6K-39.07%299.14K-49.09%249.92K-49.33%344.63K-49.33%344.63K53.72%381.81K4.99%490.91K
Free cash from -17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K49.95%-94.71K81.59%-359.93K52.82%-46.57K-184.06%-147.78K102.85%23.68K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.